Phibro Animal Health Corporation Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health (PAHC) Misses Q1 EPS by 5c, Revenues Miss; Reaffirms Previous FY Guidance
November 4, 2019 4:50 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.19, $0.05 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $190 million versus the consensus estimate of $199.67 million.
Highlights for the September 2019 quarter (compared to the September 2018 quarter)
Net sales of $190 million, a decrease of $10 million, or 5%Net income of $3 million, a decrease of $14 million, or 85%Diluted EPS of $0.06, a decrease of $0.34, or 85%Adjusted EBITDA of $20 million, a decrease of $10 million, or 35%Adjusted diluted EPS of $0.19, a decrease of $0.20, or... More


